D Amp M Pharma Peru Sac |link| Online

: These three specialized divisions focus entirely on clinical dermatology and advanced medical aesthetics. They provide targeted local therapies for severe skin conditions, anti-aging solutions, and hair care.

: In its most recent diversification, D&M Pharma has ventured into the probiotic supplement field through the BIOCASS line, an innovative product range that expands its portfolio in alimentary tract and metabolism health.

A suspension inhaler designed for respiratory therapies. d amp m pharma peru sac

To maintain its position in the pharmaceutical industry, D&M Pharma Peru adheres to strict local and international standards:

| Category | Information | | :--- | :--- | | | D & M PHARMA PERU S.A.C. | | Commercial Name | D & M PHARMA PERU S.A.C. | | RUC (Tax ID) | 20514898961 | | Company Type | Closed Corporation (Sociedad Anónima Cerrada) | | Registration Date | January 8, 2007 | | Activity Start Date | January 8, 2007 | | State | Active (ACTIVO) | | Condition | Habido (Good Standing) | | Foreign Trade Profile | Importer / Exporter | : These three specialized divisions focus entirely on

To operate legally within Peru's strict pharmaceutical market, D & M Pharma Peru S.A.C. strictly maintains compliance with the Ministry of Health's regulatory body, the ( Dirección General de Medicamentos, Insumos y Drogas ). The company operates under two foundational regulatory frameworks:

: To handle sustainable, long-term operations, D&M Pharma Perú S.A.C. was officially incorporated on August 1, 2007 . A suspension inhaler designed for respiratory therapies

You can adjust the rating or specific details to better match your actual experience.

Following this strategic alliance, D&M Pharma began its direct operations in Peru in , with the local launch of the Cassará product line. The company continued its regional expansion into Ecuador in 2018, further consolidating its international presence. In Peru, the company is headquartered in San Isidro, Lima, and its team is composed of 11 to 50 employees in a privately financed structure.